Results 221 to 230 of about 30,075 (311)

Targeting carboxypeptidase A/B activity with the phosphinic inhibitor C28 reduces the asthmatic response in a mouse model of house dust mite-induced asthma. [PDF]

open access: yesInflamm Res
Allam VSRR   +10 more
europepmc   +1 more source

Assessment of Patients With Beta‐Lactams Positive Provocation Tests by Biomarkers of IgG‐Related Neutrophil Activation

open access: yesClinical &Experimental Allergy, EarlyView.
Neutrophil activation in beta‐lactams (BL) immediate hypersensitivity reactions (IHR). Factor component analysis of IHR biomarkers suggests an IgG‐mediated mechanism. We propose Neutrophil Elastase as a biomarker of neutrophil activation in BL IHR. ABSTRACT Background Beta‐lactams (BLs) are the predominant cause of immediate allergic reactions to drugs.
Adrienne Astrid Gallizzi   +13 more
wiley   +1 more source

Is There a Place for Cannabinoids in Asthma Treatment? [PDF]

open access: yesInt J Mol Sci
Lewandowska AA   +4 more
europepmc   +1 more source

Biologic Prescription Patterns and Biomarker Determinants of First‐Line Dupilumab in Danish Adult Patients With Severe Asthma and Comorbid Atopic Dermatitis

open access: yesClinical &Experimental Allergy, EarlyView.
Almost one in five patients receiving biological treatment for severe asthma has comorbid atopic dermatitis. Patients with comorbid atopic dermatitis represent a distinct phenotype with early‐onset, allergic asthma. Comorbid atopic dermatitis impacts the choice of biologic for severe asthma in real‐life practice. IgE, immunoglobulin E; FeNO, fractional
Marianne Baastrup Soendergaard   +14 more
wiley   +1 more source

Budesonide 21-phosphate sodium salt for use as anti-inflammatory or anti-asthmatic agent.

open access: yes, 2023
Caliendo, Giuseppe   +8 more
openaire   +1 more source

Adverse Effects of Steroid Therapy in Sudden Sensorineural Hearing Loss: A Scoping Review

open access: yesClinical Otolaryngology, EarlyView.
ABSTRACT Objective Sudden sensorineural hearing loss (SSNHL) is an otologic emergency and is treated with steroid therapy. Despite adverse events (AEs) associated with long‐term steroid use being well evidenced, there is sparsity of literature regarding the AEs of short‐course prescriptions in the SSNHL cohort, which limits the quality of patient ...
M. Achanta   +5 more
wiley   +1 more source

International survey of treatment practices for atopic dermatitis in pregnant and breastfeeding women: Physician perspectives

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and Objectives Systemic treatment of pregnant/breastfeeding atopic dermatitis (AD) patients is challenging due to limited safety data. We explored treatment practices with systemic agents, including the guideline‐recommended cyclosporine as the first systemic choice as well as emerging therapies, in this vulnerable population ...
Manuel P. Pereira   +34 more
wiley   +1 more source

Home - About - Disclaimer - Privacy